The Evolution of Gene Editing: From CRISPR to TIGR #
- CRISPR-Cas9 functions as a bacterial defense mechanism that uses a "guide RNA" to identify specific DNA sequences and an enzyme to cut them.
- Feng Zhang’s lab pioneered the application of CRISPR in human cells, allowing for targeted genome editing.
- While revolutionary, CRISPR has limitations: it is primarily a "search and cut" tool, and while it can delete genes, it is less efficient at inserting large pieces of new genetic information.
The Search for "Programmable" Systems #
- Zhang’s research team looks for new tools by mining bacterial genomes for "programmable" systems—sets of genes that can be redesigned to perform specific tasks.
- Nature contains vast diversity; by searching billions of bacterial sequences, researchers can find proteins that act like modular components for molecular engineering.
TIGR: Transposon-Integrated Gene Recombinases #
- The lab has identified a group of proteins called TIGRs, which are derived from "jumping genes" (transposons) found in bacteria.
- Unlike CRISPR, which cuts DNA and relies on the cell’s often-erroneous repair machinery to fix it, TIGRs are designed to facilitate the actual insertion of DNA.
- TIGRs are highly programmable, meaning they can be engineered to target a specific "landing site" in the genome and drop off a specific "payload" of DNA.
Comparison to Current Gene Therapy Methods #
- Current gene therapies often rely on viruses (like AAV) to deliver genetic material.
- Viral delivery is limited by the size of the genetic cargo it can carry and has less control over where the new DNA is placed.
- A TIGR-based system could potentially deliver much larger genetic sequences—entire genes or sets of genes—with pinpoint accuracy.
Structural Biology and "Cryo-EM" #
- To turn these bacterial genes into human tools, the lab uses Cryo-Electron Microscopy (Cryo-EM).
- This technology allows scientists to visualize the atomic structure of proteins while they are interacting with DNA.
- By seeing how the "gears" of the TIGR machinery fit together, researchers can re-engineer them to work more efficiently in human cells.
Future Implications and Disease Treatment #
- The ultimate goal is to move beyond just disrupting a "broken" gene to actually replacing it with a healthy version.
- TIGR technology could enable the treatment of complex genetic diseases where a large gene is missing or mutated.
- This represents a shift from "gene editing" (small tweaks) to "genome engineering" (large-scale insertions).
Summary #
While CRISPR-Cas9 revolutionized biotechnology by allowing scientists to accurately cut DNA, it remains limited in its ability to reliably insert new genetic material. Feng Zhang’s lab is now developing TIGR (Transposon-Integrated Gene Recombinase), a system derived from bacterial "jumping genes." This technology is being engineered to function as a programmable delivery vehicle capable of inserting large genetic payloads into specific locations in the human genome. By leveraging structural biology tools like Cryo-EM to refine these proteins, researchers hope to move from simple gene editing to sophisticated genome engineering, potentially curing complex genetic diseases that current tools cannot address.
last updated: